Zobrazeno 1 - 10
of 13
pro vyhledávání: '"S. L. Grundy"'
Publikováno v:
The Journal of Clinical Psychiatry. 62:191-198
Background: There may be a temporal association between some antipsychotics and prolongation of the heart-rate-corrected QT interval (QTc) representing a delay in ventricular repolarization. QTc prolongation significantly exceeding normal intra-indiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6aac417d473b29f71cafaacf3c27342c
https://doi.org/10.4088/jcp.v62n0310
https://doi.org/10.4088/jcp.v62n0310
Autor:
Miroslav Miro Jakovljevic, Borben Uglesic, Philip Friedel, Vera Folnegović-Šmalc, S. L. Grundy, Gary D. Tollefson, Ljubomir Hotujac, Martin Dossenbach
This study was undertaken to evaluate the efficacy and safety of olanzapine compared with fluphenazine in the treatment of patients who met the Diagnostic and Statistical Manual, fourth edition (DSM-IV) diagnostic criteria for schizophrenia or schizo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e570aa258c5f21a20fb8eeee757aeac1
https://www.bib.irb.hr/184868
https://www.bib.irb.hr/184868
Publikováno v:
The Journal of clinical psychiatry. 62(4)
Background: Olanzapine has demonstrated efficacy in the treatment of acute mania in 2 double-blind, placebo-controlled trials. We describe the results of the open-label extension from one of these trials. Method: In a 3-week, double-blind study of pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::316ff722ec225630dc4caa4103c05b9a
https://pubmed.ncbi.nlm.nih.gov/11379842
https://pubmed.ncbi.nlm.nih.gov/11379842
Autor:
M R, Dossenbach, P, Kratky, M, Schneidman, S L, Grundy, S, Metcalfe, G D, Tollefson, R H, Belmaker
Publikováno v:
The Journal of clinical psychiatry. 62
This multicenter, open-label study evaluated the efficacy and safety of olanzapine in patients with schizophrenia who had been nonresponsive or intolerant to a course of risperidone (mean duration of risperidone treatment = 46.3 days).A total of 34 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a952e42ca1a0bb019947c7d4223c3bef
https://pubmed.ncbi.nlm.nih.gov/11232749
https://pubmed.ncbi.nlm.nih.gov/11232749
Publikováno v:
4. Bad Homburger ZNS-Gespräche ISBN: 9783540417521
Fur Neuroleptika konnten Unterschiede bei kardiovaskularen Nebenwirkungen nachgewiesen werden [1]. Wie die vorliegende EKG-Analyse zeigt, ist das atypische Neuroleptikum Olanzapin im Hinblick auf QTc-Effekte mit am vertraglichsten [2].
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18095e1ffdeac022d9ac21a707b8142f
https://doi.org/10.1007/978-3-662-05552-6_11
https://doi.org/10.1007/978-3-662-05552-6_11
Autor:
M, Tohen, T M, Sanger, S L, McElroy, G D, Tollefson, K N, Chengappa, D G, Daniel, F, Petty, F, Centorrino, R, Wang, S L, Grundy, M G, Greaney, T G, Jacobs, S R, David, V, Toma
Publikováno v:
The American journal of psychiatry. 156(5)
The primary intent of this study was to compare the efficacy and safety of olanzapine and placebo in the treatment of acute mania.The design involved a random-assignment, double-blind, placebo-controlled parallel group study of 3 weeks' duration. Aft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d60a1916d6a58c83637cf54a635f8b5b
https://pubmed.ncbi.nlm.nih.gov/10327902
https://pubmed.ncbi.nlm.nih.gov/10327902
Autor:
J.A. Lieberman, S. L. Grundy, Charles M. Beasley, Todd M. Sanger, Mauricio Tohen, Gary D. Tollefson
Publikováno v:
The American journal of psychiatry. 156(1)
It has been hypothesized that the morbidity and mortality associated with schizophrenia can be prevented by providing effective treatment during the first episode of psychosis. Hence, the authors examined patients with first-episode psychosis to dete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3379c5ca686e389064427e7ada423dea
https://pubmed.ncbi.nlm.nih.gov/9892301
https://pubmed.ncbi.nlm.nih.gov/9892301
Publikováno v:
European Neuropsychopharmacology. 8:S228-S229
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fce6ad6dee1b09157d1c326faba2faff
https://doi.org/10.1016/s0924-977x(98)80385-4
https://doi.org/10.1016/s0924-977x(98)80385-4
Autor:
Philip G. Janicak, Fan Zhang, T. Jacobs, R.C. Risser, Mauricio Tohen, Judith Francis, Michael C. Banov, S. L. Grundy, Alan Breier, V. Toma, Todd M. Sanger, Susan L. McElroy, Gary D. Tollefson
Publikováno v:
Archives of General Psychiatry. 57:841
Background We compared the efficacy and safety of olanzapine vs placebo for the treatment of acute bipolar mania. Methods Four-week, randomized, double-blind, parallel study. A total of 115 patients with aDSM-IVdiagnosis of bipolar disorder, manic or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10018eeecdfcd1c7488035100f4a2aa7
https://doi.org/10.1001/archpsyc.57.9.841
https://doi.org/10.1001/archpsyc.57.9.841
Publikováno v:
European Neuropsychopharmacology. 8:S229
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53b3b4f7b44546d362723eee34e3e08a
https://doi.org/10.1016/s0924-977x(98)80386-6
https://doi.org/10.1016/s0924-977x(98)80386-6